Table 1.
HC | naPPA | lvPPA | svPPA | P | |
---|---|---|---|---|---|
n | 31 | 15 | 23 | 21 | |
Age, y | 69.29 (7.90) | 69.67 (9.20) | 65.91 (9.83) | 64.48 (7.71) | 0.14 |
Sex = Male (%) | 11 (35.5) | 6 (40.0) | 7 (30.4) | 10 (47.6) | 0.68 |
Education, y | 15.97 (2.58) | 14.80 (3.12) | 15.35 (3.19) | 15.10 (2.81) | 0.56 |
Disease duration, y | NA | 2.60 (1.12) | 4.00 (2.00) | 4.05 (2.04) | 0.04 |
MMSE total (0‐30), n = 85 | 29.00 (1.07) | 24.73 (5.24) | 23.05 (5.72) | 23.05 (6.11) | <0.001a |
PBAC Naming (0‐6), n = 37 | 5.50 (0.71) | 5.78 (0.67) | 4.00 (1.83) | 1.23 (1.48) | <0.001 |
F letter fluency, n = 41 | 17.75 (8.10) | 6.33 (3.04) | 6.36 (5.40) | 8.21 (3.96) | 0.001 |
Digit span forward, n = 69 | 7.00 (1.37) | 5.61 (1.30) | 4.45 (1.54) | 6.06 (1.89) | <0.001 |
Digit span backward, n = 74 | 5.65 (1.31) | 2.64 (1.11) | 2.91 (1.08) | 3.78 (1.70) | <0.001 |
Category fluencyd, n = 54 | 19.67 (6.48) | 10.11 (5.09) | 9.85 (5.94) | 5.36 (4.67) | <0.001 |
Total speech timeb (sec) | 49.66 (18.23) | 33.78 (18.53) | 38.54 (15.02) | 36.42 (13.85) | 0.006 |
Total word countc | 166.32 (63.90) | 65.80 (37.06) | 114.13 (56.80) | 134.05 (55.99) | <0.001 |
Speech rate, wpm | 140.06 (36.74) | 61.00 (24.85) | 88.17 (36.09) | 113.95 (40.76) | <0.001 |
MLU (words) | 10.57 (1.98) | 6.74 (2.38) | 8.46 (2.45) | 8.61 (2.75) | <0.001 |
DC/utterancee | 0.37 (0.23) | 0.05 (0.09) | 0.21 (0.21) | 0.32 (0.27) | <0.001 |
WFS/utterance | 0.91 (0.11) | 0.72 (0.32) | 0.71 (0.25) | 0.78 (0.19) | 0.003 |
wpm, words per minute; MLU, mean length of utterance; DC, dependent clauses; WFS, well‐formed sentences; PBAC, Philadelphia Brief Assessment of Cognition.
MMSE total score did not differ between patient groups.
This refers to the sum of all subject's speech segment durations, including verbal and nonverbal vocalizations, all available for pitch‐tracking.
This manual word count includes only verbal vocalizations that were comprehensible enough for transcription.
Category = animals
Data refer to the average number of clauses per utterance.